Journal
NATURE REVIEWS GENETICS
Volume 6, Issue 3, Pages 241-246Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/nrg1559
Keywords
-
Categories
Ask authors/readers for more resources
Understanding and harnessing genomic variation will contribute significantly to improving the health of people in developing countries. We need to explore the nexus between pharmacogenetics, genotyping projects in developing countries, and the evolution of the pharmaceutical industry in both the developed and developing worlds. Here, we argue that, for the foreseeable future, we should focus not on boutique 'personalized' medicine, but on carefully defined differences between populations and ethical ways of using emerging genomics knowledge to develop drugs and improve health.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available